Published July 2010 | Version v1
Journal article

The progress of tumor gene-radiotherapy induced by Egr-1 promoter

  • 1. Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai (China)

Description

The promoter of early growth response gene-1 (Egr-1) is a cis-acting element of Egr-1, and its activity is regulated by inducers such as ionizing radiation, free radical. In designated gene-radiotherapy system, radiation combined with therapeutic gene (such as tumor necrosis factor-α gene, suicide gene) can spatially and temporally regulate therapeutic gene expression in the irradiated field, produced a marked effect, while little systemic toxicities were observed. The combination of radiotherapy and gene therapy is promising in tumor therapy. (authors)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Medicine and Nuclear Medicine
Journal Volume
34
Journal Issue
4
Journal Page Range
p. 206-208, 219
ISSN
1673-4114

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
44083295
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
GENE THERAPY; GENES; GROWTH; IONIZING RADIATIONS; NEOPLASMS; PROMOTERS; RADICALS; RADIOTHERAPY; TOXICITY
Descriptors DEC
DISEASES; MEDICINE; NUCLEAR MEDICINE; RADIATIONS; RADIOLOGY; THERAPY

Optional Information

Notes
19 refs.